Sonic Healthcare Limited (ASX:SHL)
Australia · Delayed Price · Currency is AUD 21.08
-0.30 (-1.40%)
Aug 21, 2026, 4:14 PM AEST
Sonic Healthcare Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 10,867 | 9,645 | 8,967 | 8,169 | 9,340 | |
Revenue Growth | 12.67% | 7.56% | 9.77% | -12.54% | 6.69% |
Cost of Revenue | 7,283 | 6,457 | 6,023 | 5,327 | 5,614 |
Gross Profit | 3,585 | 3,188 | 2,945 | 2,842 | 3,726 |
Selling, General & Admin | 327.32 | 267.56 | 249.79 | 217.02 | 206.13 |
Amortization of Goodwill & Intangibles | 97.55 | 92.85 | 82.92 | 71.63 | 67.99 |
Other Operating Expenses | 1,385 | 1,169 | 1,068 | 904.26 | 687.67 |
Operating Expenses | 2,581 | 2,252 | 2,095 | 1,824 | 1,569 |
Operating Income | 1,004 | 936.19 | 849.66 | 1,018 | 2,157 |
Interest Expense | -203.3 | -180.51 | -151.35 | -87.03 | -79.82 |
EBT Excluding Unusual Items | 800.63 | 755.69 | 698.31 | 931.19 | 2,077 |
Merger & Restructuring Charges | - | -4.82 | - | - | - |
Gain (Loss) on Sale of Assets | 106.75 | - | 32.34 | - | - |
Asset Writedown | -82.84 | - | - | - | - |
Pretax Income | 824.54 | 750.87 | 730.65 | 931.19 | 2,077 |
Income Tax Expense | 188.22 | 206.94 | 186.85 | 223.26 | 561.74 |
Earnings From Continuing Operations | 636.32 | 543.92 | 543.8 | 707.93 | 1,515 |
Minority Interest in Earnings | -28.03 | -30.33 | -32.71 | -22.95 | -54.9 |
Net Income | 608.29 | 513.6 | 511.09 | 684.98 | 1,461 |
Net Income to Common | 608.29 | 513.6 | 511.09 | 684.98 | 1,461 |
Net Income Growth | 18.44% | 0.49% | -25.39% | -53.10% | 11.07% |
Shares Outstanding (Basic) | 494 | 480 | 476 | 470 | 478 |
Shares Outstanding (Diluted) | 495 | 481 | 477 | 472 | 483 |
Shares Change | 2.75% | 0.91% | 0.96% | -2.16% | 0.29% |
EPS (Basic) | 1.23 | 1.07 | 1.07 | 1.46 | 3.05 |
EPS (Diluted) | 1.23 | 1.07 | 1.07 | 1.45 | 3.02 |
EPS Growth | 15.28% | -0.47% | -26.07% | -52.07% | 10.76% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 774.71 | 960.55 | 600.9 | 1,082 | 1,939 |
Free Cash Flow Per Share | 1.57 | 2.00 | 1.26 | 2.29 | 4.01 |
Dividend Per Share | 1.080 | 1.070 | 1.060 | 1.040 | 1.000 |
Dividend Growth | 0.94% | 0.94% | 1.92% | 4.00% | 9.89% |
Gross Margin | 32.99% | 33.05% | 32.84% | 34.80% | 39.90% |
Operating Margin | 9.24% | 9.71% | 9.47% | 12.46% | 23.09% |
Profit Margin | 5.60% | 5.33% | 5.70% | 8.38% | 15.64% |
Free Cash Flow Margin | 7.13% | 9.96% | 6.70% | 13.24% | 20.76% |
EBITDA | 1,873 | 1,244 | 1,152 | 1,281 | 2,413 |
EBITDA Margin | 17.23% | 12.90% | 12.84% | 15.68% | 25.83% |
D&A For EBITDA | 869.05 | 307.58 | 301.97 | 262.67 | 255.73 |
EBIT | 1,004 | 936.19 | 849.66 | 1,018 | 2,157 |
EBIT Margin | 9.24% | 9.71% | 9.47% | 12.46% | 23.09% |
Effective Tax Rate | 22.83% | 27.56% | 25.57% | 23.98% | 27.04% |
Revenue as Reported | 10,974 | 9,645 | 9,000 | 8,169 | - |